注意欠陥多動性障害(ADHD)の世界市場レポート2024-2030
英文タイトル: Global Attention Deficit Hyperactivity Disorder (ADHD) Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、注意欠陥多動性障害(ADHD)の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に注意欠陥多動性障害(ADHD)市場を分類しています。本レポートでは世界の注意欠陥多動性障害(ADHD)市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Takeda、Johnson & Johnson、Novartis、Eli Lilly、Tris Pharma、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、Noven Pharmaceuticals、Purdue Parma、CTFH
レポートは注意欠陥多動性障害(ADHD)の主要生産者を調査し、主要地域や国の消費状況も提供します。注意欠陥多動性障害(ADHD)の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別(地域レベル、国レベル)の注意欠陥多動性障害(ADHD)生産量、成長率、市場シェアを調査している。
Stimulant
Non-stimulant
用途別の市場セグメント:
Hospital Pharmacy
Retail Pharmacy
本レポートの詳細内容
本レポートは、世界の注意欠陥多動性障害(ADHD)市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて注意欠陥多動性障害(ADHD)市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、注意欠陥多動性障害(ADHD)の売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。
三.主要メーカーの注意欠陥多動性障害(ADHD)売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の注意欠陥多動性障害(ADHD)市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本注意欠陥多動性障害(ADHD)のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:注意欠陥多動性障害(ADHD)のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2020~2031)
第2章: 注意欠陥多動性障害(ADHD)の世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2020~2031)
第3章:世界、地域、国レベルにおける注意欠陥多動性障害(ADHD)の売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2020~2031)
第4章注意欠陥多動性障害(ADHD)メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2020~2025)
第5章:注意欠陥多動性障害(ADHD)の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2020~2031)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2020~2031)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2020~2031)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2020~2031)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2020~2031)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2020~2031)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2020~2031)
第12章:注意欠陥多動性障害(ADHD)の主要メーカーの概要を提供し、製品の説明と仕様、注意欠陥多動性障害(ADHD)の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2020~2025)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:注意欠陥多動性障害(ADHD)の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age. Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Market The global Attention Deficit Hyperactivity Disorder (ADHD) market is projected to grow from US$ 13130 million in 2024 to US$ 19380 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. There are two main types of drugs used to treat ADHD: stimulants and non-stimulants The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China. ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83% Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020. Report Covers: This report presents an overview of global market for Attention Deficit Hyperactivity Disorder (ADHD) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Attention Deficit Hyperactivity Disorder (ADHD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Attention Deficit Hyperactivity Disorder (ADHD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Attention Deficit Hyperactivity Disorder (ADHD) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Attention Deficit Hyperactivity Disorder (ADHD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Distribution Channel, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Attention Deficit Hyperactivity Disorder (ADHD) revenue, projected growth trends, production technology, application and end-user industry. Market Segmentation By Company Takeda Johnson & Johnson Novartis Eli Lilly Tris Pharma Neos Therapeutics Mallinckrodt Amneal Pharmaceuticals Noven Pharmaceuticals Purdue Parma CTFH Segment by Type Stimulant Non-stimulant Segment by Distribution Channel Hospital Pharmacy Retail Pharmacy By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Attention Deficit Hyperactivity Disorder (ADHD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Distribution Channel and by country, revenue for each segment. Chapter 7: Europe by Type, by Distribution Channel and by country, revenue for each segment. Chapter 8: China by Type, and by Distribution Channel, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Distribution Channel and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Distribution Channel and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Attention Deficit Hyperactivity Disorder (ADHD) revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Distribution Channel
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2019-2030)
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
2.2.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2019-2024)
2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2025-2030)
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Attention Deficit Hyperactivity Disorder (ADHD) by Players
3.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2019-2024)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2019-2024)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2023
3.5 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Head office and Area Served
3.6 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Product and Application
3.7 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2019-2024)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2025-2030)
5 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Distribution Channel
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2019-2024)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2025-2030)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
6.2.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
6.2.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
6.2.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030)
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
6.3.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
6.3.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
6.3.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030)
6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
6.4.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)
6.4.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
7.2.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
7.2.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
7.2.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
7.3.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
7.3.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
7.3.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030)
7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
7.4.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)
7.4.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
8.2 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
8.2.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
8.2.2 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
8.2.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030)
8.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
8.3.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
8.3.2 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
8.3.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030)
9 Asia (excluding China)
9.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
9.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
9.2.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
9.2.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
9.2.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030)
9.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
9.3.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
9.3.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
9.3.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030)
9.4 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region
9.4.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024)
9.4.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
10.3.1 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
10.3.2 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
10.3.3 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030)
10.4 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.1.5 Takeda Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.5.5 Tris Pharma Recent Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.6.5 Neos Therapeutics Recent Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.7.5 Mallinckrodt Recent Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.8.5 Amneal Pharmaceuticals Recent Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.9.5 Noven Pharmaceuticals Recent Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.10.5 Purdue Parma Recent Developments
11.11 CTFH
11.11.1 CTFH Company Details
11.11.2 CTFH Business Overview
11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.11.4 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)
11.11.5 CTFH Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Stimulant Table 3. Key Players of Non-stimulant Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2019-2024) Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2025-2030) Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players (2019-2024) Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2023) Table 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Headquarters and Area Served Table 20. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Product and Application Table 21. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024) Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2025-2030) Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2024) Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2025-2030) Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 34. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 35. North America Attention Deficit Hyperactivity Disorder (ADHD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 41. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million) Table 45. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 46. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (US$ Million) Table 47. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 48. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 49. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 52. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 53. Asia Attention Deficit Hyperactivity Disorder (ADHD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million) Table 63. Takeda Company Details Table 64. Takeda Business Overview Table 65. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Table 66. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 67. Takeda Recent Developments Table 68. Johnson & Johnson Company Details Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Table 71. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 72. Johnson & Johnson Recent Developments Table 73. Novartis Company Details Table 74. Novartis Business Overview Table 75. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Table 76. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 77. Novartis Recent Developments Table 78. Eli Lilly Company Details Table 79. Eli Lilly Business Overview Table 80. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Table 81. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 82. Eli Lilly Recent Developments Table 83. Tris Pharma Company Details Table 84. Tris Pharma Business Overview Table 85. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Table 86. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 87. Tris Pharma Recent Developments Table 88. Neos Therapeutics Company Details Table 89. Neos Therapeutics Business Overview Table 90. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Table 91. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 92. Neos Therapeutics Recent Developments Table 93. Mallinckrodt Company Details Table 94. Mallinckrodt Business Overview Table 95. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Table 96. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 97. Mallinckrodt Recent Developments Table 98. Amneal Pharmaceuticals Company Details Table 99. Amneal Pharmaceuticals Business Overview Table 100. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Table 101. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 102. Amneal Pharmaceuticals Recent Developments Table 103. Noven Pharmaceuticals Company Details Table 104. Noven Pharmaceuticals Business Overview Table 105. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Table 106. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 107. Noven Pharmaceuticals Recent Developments Table 108. Purdue Parma Company Details Table 109. Purdue Parma Business Overview Table 110. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Table 111. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 112. Purdue Parma Recent Developments Table 113. CTFH Company Details Table 114. CTFH Business Overview Table 115. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product Table 116. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million) Table 117. CTFH Recent Developments Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2023 VS 2030 Figure 3. Stimulant Features Figure 4. Non-stimulant Features Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2023 VS 2030 Figure 7. Hospital Pharmacy Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2023 VS 2030 Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2023 Figure 14. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2023) Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2023 Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030) Figure 18. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030) Figure 19. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030) Figure 20. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 21. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2019-2030) & (US$ Million) Figure 23. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030) Figure 24. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030) Figure 25. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030) Figure 26. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Nordic Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2019-2030) & (US$ Million) Figure 33. China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030) Figure 34. China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030) Figure 35. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2019-2030) & (US$ Million) Figure 36. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030) Figure 37. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030) Figure 38. Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2019-2030) Figure 39. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 40. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. China Taiwan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2019-2030) Figure 47. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel (2019-2030) Figure 48. Middle East, Africa, and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030) Figure 49. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Israel Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. GCC Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 56. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 57. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 58. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 59. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 60. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 61. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 62. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 63. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 64. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 65. CTFH Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)